Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

Thompson, Ian M.; Tangen, Catherine M.; Paradelo, Jorge C.; Lucia, M. Scott; Miller, Gary J.; Troyer, Dean A.; Messing, Edward M.; Forman, Jeffrey D.; Chin, Joseph L.; Swanson, Gregory P.; Canby‐Hagino, Edith; Crawford, E. David

doi:10.1016/j.juro.2008.11.032

articleThe Journal of UrologyJan 24, 2009GREEN OA

Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

IMIan M. Thompson CMCatherine M. Tangen JCJorge C. Paradelo MSM. Scott Lucia GJGary J. Miller

The University of Texas Health Science Center at San Antonio · Fred Hutch Cancer Center · +7 more institutions

Indexed incrossref

Abstract

Adjuvant radiotherapy after radical prostatectomy for a man with pT3N0M0 prostate cancer significantly reduces the risk of metastasis and increases survival.

Citation impact

1,228

total citations

FWCI: 81.86
Percentile: 100%
References: 30

Citations per year

Authors

IM
Ian M. ThompsonCorresponding
The University of Texas Health Science Center at San Antonio
CM
Catherine M. Tangen
Fred Hutch Cancer Center
JC
Jorge C. Paradelo
MS
M. Scott Lucia
University of Colorado Health, University of Colorado Hospital, University of Colorado Denver
GJ
Gary J. Miller
University of Colorado Denver, University of Colorado Health, University of Colorado Hospital

Topics & keywords

Topics

Prostate Cancer Treatment and Research100%
Prostate Cancer Diagnosis and Treatment100%
Hepatocellular Carcinoma Treatment and Prognosis98%

Keywords

Medicine
Radiation therapy
Prostate cancer
Prostatectomy
Randomized controlled trial
Oncology
Internal medicine
Metastasis

UN Sustainable Development Goals

Good health and well-being

No related works found for this paper.